BEPRO TECHNOLOGY Trademark

Trademark Overview

On Friday, October 1, 2021, a trademark application was filed for BEPRO TECHNOLOGY with the United States Patent and Trademark Office. The USPTO has given the BEPRO TECHNOLOGY trademark a serial number of 97056902. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, September 27, 2024. This trademark is owned by Ligand Pharmaceuticals Incorporated. The BEPRO TECHNOLOGY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development of a process to deliver pharmaceutical preparations
bepro technology

General Information

Serial Number97056902
Word MarkBEPRO TECHNOLOGY
Filing DateFriday, October 1, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, September 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 16, 2022

Trademark Statements

Description of MarkThe mark consists of the letters "BEPRO" in a bold font with the letters "BEP" capitalized. The word "TECHNOLOGY" is written in lowercase lettering beneath "BEPRO". A stylized drawing of a chemical molecule is to the right of the wording "BEPRO TECHNOLOGY".
Pseudo MarkBE PRO TECHNOLOGY
NOT AVAILABLE"TECHNOLOGY"
Goods and ServicesPharmaceutical research and development of a process to deliver pharmaceutical preparations

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 28, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLigand Pharmaceuticals Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameLigand Pharmaceuticals Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608

Trademark Events

Event DateEvent Description
Tuesday, October 5, 2021NEW APPLICATION ENTERED
Thursday, October 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 29, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, July 7, 2022EXAMINERS AMENDMENT E-MAILED
Friday, July 1, 2022ASSIGNED TO EXAMINER
Thursday, July 7, 2022NON-FINAL ACTION WRITTEN
Thursday, July 7, 2022NON-FINAL ACTION E-MAILED
Thursday, July 7, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 7, 2022EXAMINERS AMENDMENT -WRITTEN
Thursday, July 7, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, July 7, 2022EXAMINER'S AMENDMENT ENTERED
Thursday, July 14, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 27, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 11, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 16, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 16, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, April 10, 2023SOU TEAS EXTENSION RECEIVED
Monday, April 10, 2023SOU EXTENSION 1 FILED
Monday, April 10, 2023SOU EXTENSION 1 GRANTED
Wednesday, April 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 9, 2023SOU TEAS EXTENSION RECEIVED
Monday, October 9, 2023SOU EXTENSION 2 GRANTED
Monday, October 9, 2023SOU EXTENSION 2 FILED
Saturday, April 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 5, 2024SOU TEAS EXTENSION RECEIVED
Friday, April 5, 2024SOU EXTENSION 3 FILED
Friday, April 5, 2024SOU EXTENSION 3 GRANTED
Friday, September 27, 2024SOU TEAS EXTENSION RECEIVED
Friday, September 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 27, 2024SOU EXTENSION 4 FILED
Friday, September 27, 2024SOU EXTENSION 4 GRANTED

Related Keywords

technology bepro pharmaceutical preparations deliver development research process